Cardinal Health Archives - Page 2 of 3 - Medical Design Sourcing

Cardinal Health starts Zipline drone deliveries of drugs and medical supplies

Zipline’s fixed-wing drones are delivering medical supplies in North Carolina. [Image courtesy of Zipline]

Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina.

San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight.

The flights starting today are out of Zipline’s hub in Kannapolis, North Carolina, on behalf of Cardinal Health as well as Novant Health and Magellan Rx Management.

Zipline said the hub can serve customers within a 7,800-square-mile area in as little as 15 minutes, with 98 percent lower emissions than traditional delivery options.

Get the full story at our sister site, Medical Design & Outsourcing.

Cardinal Health starts Zipline drone deliveries of drugs and medical supplies

Zipline’s fixed-wing drones are delivering medical supplies in North Carolina. [Image courtesy of Zipline]

Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina.

San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight.

The flights starting today are out of Zipline’s hub in Kannapolis, North Carolina, to Cardinal Health as well as Novant Health and Magellan Rx Management.

Zipline said the hub can serve customers within a 7,800-square-mile area in as little as 15 minutes, with 98 percent lower emissions than traditional delivery options.

“We imagine a future in which goods are transported nearly instantly,” Zipline founder and CEO Keller …

Cardinal Health opens new distribution center in Ohio

[Image from Cardinal Health]

Cardinal Health (NYSE:CAH) announced today that it added a new distribution center in the Columbus, Ohio area.

Dublin, Ohio–based Cardinal Health’s new distribution center, which folds into its multi-year warehouse modernization and growth strategy, will support its at-home solutions business that provides medical supplies for comfortable care in the home for those with chronic and serious health conditions.

According to a news release, the 208,144 square-foot building in Grove City, Ohio, will become the 10th distribution center for Cardinal Health’s at-home solutions business. It will integrate state-of-the-art logistics technology, including robotic storage capabilities, conveyance and the Kinaxis RapidResponse platform to optimize digital supply chain planning.

The distribution center will create approximately 100 new job opportunities in the Ohio Valle…

Ember Technologies, Cardinal Health partner on self-refrigerated, cloud-based shipping box

[Image from Ember Technologies]

Ember Technologies and Cardinal Health (NYSE:CAH) announced that they are partnering on the Ember Cube digital shipping box.

The two companies will collaborate to offer what they are touting as the world’s first self-refrigerated, cloud-based shipping box, according to a news release. They will work together to deliver a cold chain solution designed to ensure product integrity and security throughout the supply chain while also significantly reducing shipping waste in the transport of temperature-sensitive medicines.

Get the full story at our sister site, MassDevice.

Cardinal Health profits take a big hit in Q2

Cardinal Health (NYSE:CAH) today reported mixed second quarter results and cut its EPS guidance as the company’s Medical segment continues to wrestle with inflation and supply chain problems.

The Dublin, Ohio–based pharma and medtech giant reported profits of $49 million, or 17¢ per share, on sales of $45.5 million for the three months ended Dec. 31, 2021, for a bottom-line drop of 92% on top-line growth of 9%.

Adjusted to exclude one-time items, earnings per share were $1.27, 4¢ ahead of The Street, where analysts were looking EPS of $1.23 on sales of $45.57 billion.

Get the full story on our sister site MassDevice.

Cardinal Health to pay $13M to settle claims it paid kickbacks to doctors

The U.S. Justice Dept. (DOJ) announced that Cardinal Health (NYSE:CAH) agreed to pay more than $13 million to resolve kickback allegations.

Allegations against Dublin, Ohio-based include a violation of the False Claims Act by paying “upfront discounts” to its physician practice customers in violation of the Anti-Kickback Statute.

The Anti-Kickback Statute prevents pharmaceutical distributors from offering or paying any compensation to induce physicians to purchase drugs for use on Medicare patients, according to a DOJ news release. According to the acknowledged facts in the settlement agreement, Cardinal Health failed to meet requirements as the upfront discounts it provided to customers were not attributable to identifiable sales or were purported rebates that had not been earned by Cardinal Health customers.

“Cardinal Health recruited new customers by offering and paying cash bonuses in violation of the Anti-Kickback Statute and False Claim…

Johnson & Johnson reaches opioid settlement with Colorado and Nevada

Johnson & Johnson (NYSE:JNJ) has reached a settlement agreement with Colorado and Nevada to put opioid-related allegations there to bed.

Colorado will receive $385 million from Johnson & Johnson and the drug distributors McKesson (NYSE:MCK), AmerisourceBergen (NYSE: ABC) and Cardinal Health (NYSE:CAH).

Nevada will receive nearly $285.2 million as part of the overall settlement, which is earmarked for battling the ongoing opioid epidemic, according to Nevada Attorney General Aaron D. Ford. Of that sum, Johnson & Johnson will pay $63 million, according to a press release.

“The funds that our state will receive going forward will help us save lives and mitigate the harms done to our residents because of the ongoing opioid epidemic,” Ford said in a statement. “Our team has worked diligently to get Nevada the resources we must have to help Nevadans in need in one of the epidemic’s hardest-hit states, and to obtain justice from many opioid manufac…

The 100 largest medical device companies in the world

Nearly half a trillion dollars — $421 billion to be exact — that’s how much the world’s 100 largest medical device companies brought in over the past year amid the COVID-19 pandemic.

That’s one of the big takeaways from the Big 100, MassDevice and Medical Design & Outsourcing‘s annual analysis of the worlds’ 100 largest medtech companies. (Check out the full Big 100 rankings here.)

Aggregate revenue for approximately 100 of the largest medical technology companies dropped 1.2% in 2020 compared to 2019. But that’s not bad considering that the worst pandemic in a century was taking place, sparking a global recession in its wake.

Some medtech businesses that played critical roles fighting the pandemic — such as 3M’s Health Care segment and Hologic — even saw revenues increase and rose in the Big 100 rankings as a result.

Check out the full Big 100 rankings here>>

Women researchers receive a fraction of funding from the world’s biggest medtech companies

The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians.

Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments data.

Among the 20 medical device companies that fund research by U.S. physicians are 3M, Abbott, BD, Boston Scientific, Johnson & Johnson (dba J&J Surgical Vision and J&J Vision Care), Medtronic (dba Medtronic, Medtronic Minimed, Medtronic USA, Medtronic Vascular), Royal Philips (dba Philips Electronics), Stryker and Zimmer Biomet.

Together, those companies paid $3.9 million to 312 doctors in 2020, but only 21 were women, receiving a collective $402,600.

Women physicians, on average, received 15.7% of payments from each of the top medtech companies, but accounted f…

Cardinal Health docks executive bonuses over opioid costs

Cardinal Health CEO Mike Kaufmann (Photo courtesy of Cardinal Health)

Cardinal Health’s board of directors reduced bonus payouts for CEO Mike Kaufmann and his four top-paid executives due to the cost of opioid litigation.

After pressure from investors, Cardinal Health (NYSE:CAH) for the first time has disclosed how its board of directors factored the opioid litigation settlement costs into the pay packages of Kaufmann, Chief Financial Officer Jason Hollar, Pharmaceutical Segment CEO Victor Crawford, Medical Segment CEO Stephen Mason and Chief Legal and Compliance Officer Jessica Mayer.

Get the full story at our sister site, Pharmaceutical Processing World.

Cardinal Health docks executive bonuses over opioid costs

Cardinal Health CEO Mike Kaufmann (Photo courtesy of Cardinal Health)

Cardinal Health’s board of directors reduced bonus payouts for CEO Mike Kaufmann and his four top-paid executives due to the cost of opioid litigation.

After pressure from investors, Cardinal Health (NYSE:CAH) for the first time has disclosed how its board of directors factored the opioid litigation settlement costs into the pay packages of Kaufmann, Chief Financial Officer Jason Hollar, Pharmaceutical Segment CEO Victor Crawford, Medical Segment CEO Stephen Mason and Chief Legal and Compliance Officer Jessica Mayer.

Kaufmann was eligible for about $2.2 million in annual incentives for fiscal 2021 and received $780,000. The board eliminated any payout to Kaufmann for the earnings component of his annual cash incentive award, but awarded him 40% of his target, according to a new Securities and Exchange Commission disclosure filed Fri…

Cardinal Health expands pharmaceutical distirbution contracts with CVS Health

Cardinal Health (NYSE:CAH) announced today that it extended agreements with CVS Health over pharmaceutical distribution.

The agreements for the distribution of pharmaceuticals to retail pharmacies and distribution centers run through June 30, 2027, according to a news release.

“We value our long-standing partnership with CVS Health, and we are honored to continue our important work together to bring our best-in-class abilities together for their customers,” Cardinal Health CEO Mike Kaufmann said in the release.

The agreement has no bearings on Cardinal Health’s financial projections, with the company’s 2022 adjusted EPS guidance range remaining between $5.60 and $5.90.